CervoMed
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,757 | $1,917 | $2,162 | $1,940 |
Gross Profit | -2,920 | -4,924 | -3,185 | |
EBITDA | -6,616 | -5,303 | -7,241 | -5,396 |
EBIT | -6,616 | -5,303 | -7,241 | -5,396 |
Net Income | -6,258 | -4,894 | -6,706 | -4,754 |
Net Change In Cash | 1,757 | 1,917 | 2,162 | 1,940 |
Free Cash Flow | -6,514 | -3,894 | -8,050 | -8,093 |
Cash | 8,320 | 10,501 | 8,999 | 7,743 |
Basic Shares | 8,950 | 8,703 | 8,703 | 8,703 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,738 | $7,145 | $0 | $0 |
Gross Profit | -9,060 | -1,294 | -1,336 | -93 |
EBITDA | -18,227 | -2,172 | -3,475 | -24,446 |
EBIT | -16,290 | -2,171 | -15,972 | -24,539 |
Net Income | -16,291 | -2,172 | -15,591 | -24,096 |
Net Change In Cash | 9,738 | 7,145 | 0 | 0 |
Free Cash Flow | -16,530 | -7,449 | -2,572 | -14,501 |
Cash | 8,999 | 7,792 | 4,093 | 37,313 |
Basic Shares | 8,073 | 2,661 | 518 | 1,302 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.70 |
2025-03-31 | -$0.56 |
2024-12-31 | -$0.80 |
2024-09-30 | -$0.54 |
